LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Martin Mense, Ph.D., principal scientist and head of Cystic Fibrosis biology at EPIX, is scheduled to present at the 22nd Annual North American Cystic Fibrosis Conference on Friday, October 24, 2008. Dr. Mense will participate in a symposium entitled “Building the CF Therapeutic Pipeline,” and the focus of his presentation will be the dual-acting compounds recently discovered at EPIX using the company’s highly efficient discovery platform.
